Competition

2026 Daiichi Sankyo Golden Ticket

Open

Daiichi Sankyo and BioLabs are hosting a competition for early-stage biotech startups developing novel technology platforms or modalities for drug candidates. Winners receive a one-year membership and lab bench space at BioLabs San Diego, along with mentorship from Daiichi Sankyo experts.

See your fit

Key facts

Organiser
Daiichi Sankyo and BioLabs
Deadline
January 8, 2027
Amount
No cash
Open to
Not stated
Stages
Pre-seed, Seed
Sectors
Biotech

5 details are locked

See your fit: whether you qualify, the official application form, and Autopilot to fill it in for you. Equity, fees, format and location open with it.

See your fit

Key questions about 2026 Daiichi Sankyo Golden Ticket

Who can apply to 2026 Daiichi Sankyo Golden Ticket?

2026 Daiichi Sankyo Golden Ticket is aimed at startups at these stages: Pre-seed and Seed. Only startups in these sectors qualify: Biotech. Other requirements: Novel technology platform or modality providing several drug candidates; Medical device, diagnostics and manufacturing are out of scope.

When is the 2026 Daiichi Sankyo Golden Ticket deadline?

The 2026 Daiichi Sankyo Golden Ticket deadline is January 8, 2027.

Other programs in this category

Verified on November 19, 2026 against the official page.